BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 28931539)

  • 1. Detachment-induced E-cadherin expression promotes 3D tumor spheroid formation but inhibits tumor formation and metastasis of lung cancer cells.
    Powan P; Luanpitpong S; He X; Rojanasakul Y; Chanvorachote P
    Am J Physiol Cell Physiol; 2017 Nov; 313(5):C556-C566. PubMed ID: 28931539
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Anoikis Effector Bit1 Inhibits EMT through Attenuation of TLE1-Mediated Repression of E-Cadherin in Lung Cancer Cells.
    Yao X; Pham T; Temple B; Gray S; Cannon C; Chen R; Abdel-Mageed AB; Biliran H
    PLoS One; 2016; 11(9):e0163228. PubMed ID: 27655370
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Multi-channel promotion of lung cancer progress by bone marrow derived mesenchymal stem cells in tumor microenvironment].
    Luo D; Hu SY; Liu GX
    Zhonghua Zhong Liu Za Zhi; 2018 Feb; 40(2):85-91. PubMed ID: 29502366
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancer Stem Cells Protect Non-Stem Cells From Anoikis: Bystander Effects.
    Kim SY; Hong SH; Basse PH; Wu C; Bartlett DL; Kwon YT; Lee YJ
    J Cell Biochem; 2016 Oct; 117(10):2289-301. PubMed ID: 26918647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Knockdown of long non-coding RNA linc-ITGB1 inhibits cancer stemness and epithelial-mesenchymal transition by reducing the expression of Snail in non-small cell lung cancer.
    Guo L; Sun C; Xu S; Xu Y; Dong Q; Zhang L; Li W; Wang X; Ying G; Guo F
    Thorac Cancer; 2019 Feb; 10(2):128-136. PubMed ID: 30485693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
    Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y
    Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fibronectin regulates anoikis resistance via cell aggregate formation.
    Han HJ; Sung JY; Kim SH; Yun UJ; Kim H; Jang EJ; Yoo HE; Hong EK; Goh SH; Moon A; Lee JS; Ye SK; Shim J; Kim YN
    Cancer Lett; 2021 Jun; 508():59-72. PubMed ID: 33771684
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathologically decreased expression of miR-193a contributes to metastasis by targeting WT1-E-cadherin axis in non-small cell lung cancers.
    Chen J; Gao S; Wang C; Wang Z; Zhang H; Huang K; Zhou B; Li H; Yu Z; Wu J; Chen C
    J Exp Clin Cancer Res; 2016 Nov; 35(1):173. PubMed ID: 27821145
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KRAS Activation in Gastric Adenocarcinoma Stimulates Epithelial-to-Mesenchymal Transition to Cancer Stem-Like Cells and Promotes Metastasis.
    Yoon C; Till J; Cho SJ; Chang KK; Lin JX; Huang CM; Ryeom S; Yoon SS
    Mol Cancer Res; 2019 Sep; 17(9):1945-1957. PubMed ID: 31217166
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLE1 promotes EMT in A549 lung cancer cells through suppression of E-cadherin.
    Yao X; Ireland SK; Pham T; Temple B; Chen R; Raj MH; Biliran H
    Biochem Biophys Res Commun; 2014 Dec; 455(3-4):277-84. PubMed ID: 25446087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Suppression of a cancer stem-like phenotype mediated by alpha-lipoic acid in human lung cancer cells through down-regulation of β-catenin and Oct-4.
    Phiboonchaiyanan PP; Chanvorachote P
    Cell Oncol (Dordr); 2017 Oct; 40(5):497-510. PubMed ID: 28677037
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSC-3436 inhibits TWIST-induced epithelial-mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma.
    Lai YJ; Yu WN; Kuo SC; Ho CT; Hung CM; Way TD; Chen CT
    J Cell Physiol; 2019 Jun; 234(6):9118-9129. PubMed ID: 30341909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ciprofloxacin mediates cancer stem cell phenotypes in lung cancer cells through caveolin-1-dependent mechanism.
    Phiboonchaiyanan PP; Kiratipaiboon C; Chanvorachote P
    Chem Biol Interact; 2016 Apr; 250():1-11. PubMed ID: 26947806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARNP, a participant in mRNA splicing and export, negatively regulates E-cadherin expression via interaction with pinin.
    Kang GJ; Park MK; Byun HJ; Kim HJ; Kim EJ; Yu L; Kim B; Shim JG; Lee H; Lee CH
    J Cell Physiol; 2020 Feb; 235(2):1543-1555. PubMed ID: 31313837
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The functional activity of E-cadherin controls tumor cell metastasis at multiple steps.
    Na TY; Schecterson L; Mendonsa AM; Gumbiner BM
    Proc Natl Acad Sci U S A; 2020 Mar; 117(11):5931-5937. PubMed ID: 32127478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of Twist and E-cadherin protein expression in primary non-small-cell lung carcinoma and corresponding metastases.
    Wang G; Dong W; Shen H; Mu X; Li Z; Lin X; Liu Y; Du J
    Eur J Cardiothorac Surg; 2011 Jun; 39(6):1028-32. PubMed ID: 21376622
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic activation of SIN1 promotes NSCLC cell proliferation and metastasis by affecting the epithelial-mesenchymal transition.
    Hu Z; Wang Y; Wang Y; Zang B; Hui H; You Z; Wang X
    Biochem Biophys Res Commun; 2017 Jan; 483(1):645-651. PubMed ID: 27993679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epithelial requirement for in vitro proliferation and xenograft growth and metastasis of MDA-MB-468 human breast cancer cells: oncogenic rather than tumor-suppressive role of E-cadherin.
    Hugo HJ; Gunasinghe NPAD; Hollier BG; Tanaka T; Blick T; Toh A; Hill P; Gilles C; Waltham M; Thompson EW
    Breast Cancer Res; 2017 Jul; 19(1):86. PubMed ID: 28750639
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpression of Aiolos promotes epithelial-mesenchymal transition and cancer stem cell-like properties in lung cancer cells.
    Hung JJ; Kao YS; Huang CH; Hsu WH
    Sci Rep; 2019 Feb; 9(1):2991. PubMed ID: 30816208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epithelial-Mesenchymal Transition in Non Small-cell Lung Cancer.
    Tsoukalas N; Aravantinou-Fatorou E; Tolia M; Giaginis C; Galanopoulos M; Kiakou M; Kostakis ID; Dana E; Vamvakaris I; Korogiannos A; Tsiambas E; Salemis N; Kyrgias G; Karameris A; Theocharis S
    Anticancer Res; 2017 Apr; 37(4):1773-1778. PubMed ID: 28373440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.